Management of Livedo Reticularis

Diagnostic Evaluation and Management Approach

• The American Heart Association recommends antiphospholipid antibody testing for patients with suspected secondary livedo reticularis, particularly with systemic symptoms, and coagulation studies to evaluate for prothrombotic states 1
• For antiphospholipid antibody syndrome, antiplatelet and/or anticoagulant therapy is often required, though the livedo pattern may persist despite treatment, according to the American College of Cardiology 1
• Careful monitoring of anticoagulation therapy is crucial for patients with antiphospholipid antibody syndrome, as recommended by the American Heart Association 1